NGT3VC

About

Portfolio · 1

Nurami Medical

A biotechnology-driven company advancing innovation in soft-tissue repair, leveraging nanofibers and engineered biomaterials to transform patient recovery.

Led ★ 3 rounds $7.5M committed Latest: 2020-11

Q&A

What is NGT3VC's primary investment focus?

NGT3VC is an Israeli government-licensed technological incubator and venture capital fund that focuses on early-stage life sciences and medical device companies.

Where is NGT3VC headquartered?

NGT3VC is headquartered in Nazareth, Israel.

What is NGT3VC's investment thesis?

NGT3VC invests in early-stage medical device/life science startups with a well-defined unmet market need, large potential market, novel technologies with strong IP coverage, and strong management. It focuses on a triple bottom line: developing cutting-edge medical technologies, providing high financial returns, and fostering social inclusion and multicultural collaboration.

What investment stages does NGT3VC target?

NGT3VC targets Early stage and Seed investments.

What is the typical check size for NGT3VC investments?

NGT3VC's check size ranges from $72,000 to $5,000,000 USD.

Who are the managing partners at NGT3VC?

The managing partners at NGT3VC are Zohar Gendler, who serves as Managing Partner & CEO, and Nizar Mishael, who is the Managing Partner & CFO.

What is the current operating name for NGT3VC?

NGT3VC's operations continue today under the name NGT HealthCare II.

What social agenda does NGT3VC aim to foster?

NGT3VC aims to foster a social agenda of inclusion and multicultural collaboration by encouraging Arab and Jewish entrepreneurship in Israel.